Actos Bladder Cancer Settlement
Posted in Drug & Medical Devices on April 30, 2015
Pharmaceutical giant Takeda has agreed to a $2.4 billion settlement to compensate plaintiffs who allege they developed bladder cancer after taking the diabetes medication, Actos® (pioglitazone). Officials at Takeda Pharmaceutical Co. said the offer will resolve a “vast majority” of the more than 8,000 Actos bladder cancer claims. In a press release, the company explained,...
Artificial Sweeteners Linked to Diabetes
Posted in Health & Wellness on September 17, 2014
A new study indicates that using artificial sweeteners may actually raise blood sugar levels, increasing the risk of developing type 2 diabetes. Researchers in Israel have discovered that zero calorie sweeteners can affect the composition of intestinal microbes called “gut bacteria,” which can alter blood glucose levels. The study, published in the journal of...
Jury Awards $9 Billion in Actos Litigation
Posted in Drug & Medical Devices on April 9, 2014
In one of the largest jury awards in U.S. history, the manufacturers of the diabetes treatment Actos® were ordered to pay $1.5 million in compensatory damages and $9 billion in punitive damages over hidden cancer risks. According to court documents, a federal court jury found that pharmaceutical giants Takeda and Eli Lilly acted with...
New Safety Review of Diabetes Drugs
Posted in Drug & Medical Devices on June 13, 2013
Possible link to cancer The American Diabetes Association (ADA) has called for an independent safety review of drugs used to control blood sugar for patients with Type 2 Diabetes. The ADA issued a statement this week asking pharmaceutical companies to “make patient-level data on their products available for an independent review that could...
Is Pfizer Benefiting From Negligence?
Posted in Drug & Medical Devices on May 20, 2013
Pfizer announces partnership with Merck to develop a new drug to treat Type 2 Diabetes… the very disease that their blockbuster medication, LIPITOR® is accused of causing. A number of recent studies have revealed an increased risk for LIPITOR users to develop Type 2 Diabetes. Lawsuits are mounting against Pfizer, the drug’s creator; alleging...
Posted in Drug & Medical Devices on May 16, 2013
Pfizer’s blockbuster cholesterol-lowering medication LIPITOR® (atorvastatin) has recently been associated with an increased risk of Type 2 Diabetes in women. Lawsuits have been filed in courts around the country claiming that Pfizer failed to warn doctors and patients about the potential risks involved with using the drug. South Carolina – Evalina Smalls thought she...
Ohio drug injury attorneys: Diabetic wonder drugs may damage pancreas
Posted in Drug & Medical Devices on April 1, 2013
Are you one of the millions of Americans with Type 2 Diabetes? If you are, you probably have struggled with ways to keep the disease in check. For many, exercise and diet are enough. For others, medication is necessary to regulate their blood glucose levels. Two popular diabetes drugs—Januvia and Byetta—have been prescribed to...